Aberdeen Wealth Management’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-250
Closed -$15.4K 432
2026
Q1
$15.4K Hold
250
0.01% 167
2025
Q4
$16.3K Hold
250
0.01% 166
2025
Q3
$14.7K Hold
250
0.01% 157
2025
Q2
$14.1K Hold
250
0.01% 157
2025
Q1
$15.2K Hold
250
0.01% 151
2024
Q4
$14.6K Hold
250
0.01% 156
2024
Q3
$16.3K Hold
250
0.01% 159
2024
Q2
$15.3K Hold
250
0.01% 161
2024
Q1
$15.5K Hold
250
0.01% 165
2023
Q4
$14.3K Hold
250
0.01% 154
2023
Q3
$13.5K Hold
250
0.01% 152
2023
Q2
$14K Hold
250
0.01% 151
2023
Q1
$13.7K Hold
250
0.01% 158
2022
Q4
$14.2K Hold
250
0.01% 157
2022
Q3
$13K Hold
250
0.01% 151
2022
Q2
$13K Hold
250
0.01% 155
2022
Q1
$14K Hold
250
0.01% 160
2021
Q4
$15K Buy
+250
New +$14.3K 0.01% 152
2021
Q2
Sell
-250
Closed -$13K 142
2021
Q1
$13K Hold
250
0.01% 141
2020
Q4
$12K Hold
250
0.01% 147
2020
Q3
$11K Buy
+250
New +$11.3K 0.01% 128
2020
Q1
Sell
-250
Closed -$11K 134
2019
Q4
$11K Buy
+250
New +$10.1K 0.01% 148

Other funds holding IYH

Aberdeen Wealth Management's IYH Position: Q2 2026 in Review

Aberdeen Wealth Management sold out of iShares US Healthcare ETF (IYH) in Q2 2026, closing a stake of 250 shares — an estimated $15.4K sold.

Aberdeen Wealth Management first reported a position in IYH in Q4 2019 and held it in 22 quarters. The position peaked at $16.3K in Q4 2025. 529 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • Aberdeen Wealth Management reported no remaining iShares US Healthcare ETF position as of Q2 2026 after selling out during the quarter.
  • Aberdeen Wealth Management sold 250 iShares US Healthcare ETF shares in Q2 2026, an estimated $15.4K.
  • Aberdeen Wealth Management first reported a position in iShares US Healthcare ETF in Q4 2019 and held it in 22 quarters.
  • Aberdeen Wealth Management's iShares US Healthcare ETF position peaked at $16.3K in Q4 2025.
  • 529 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.